XOMA Operating Margin from 2010 to 2024
| XOMA Stock | USD 30.07 0.05 0.17% |
Check XOMA Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XOMA Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 855 K, Interest Expense of 540.5 K or Total Revenue of 4.5 M, as well as many indicators such as Price To Sales Ratio of 54.07, Dividend Yield of 0.0178 or PTB Ratio of 2.27. XOMA financial statements analysis is a perfect complement when working with XOMA Corp Valuation or Volatility modules.
XOMA | Operating Margin |
Latest XOMA Corp's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of XOMA Corp over the last few years. It is XOMA Corp's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in XOMA Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.23) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
XOMA Operating Margin Regression Statistics
| Arithmetic Mean | (2.93) | |
| Geometric Mean | 1.50 | |
| Coefficient Of Variation | (129.61) | |
| Mean Deviation | 2.93 | |
| Median | (1.64) | |
| Standard Deviation | 3.79 | |
| Sample Variance | 14.39 | |
| Range | 11.523 | |
| R-Value | (0.35) | |
| Mean Square Error | 13.60 | |
| R-Squared | 0.12 | |
| Significance | 0.20 | |
| Slope | (0.30) | |
| Total Sum of Squares | 201.44 |
XOMA Operating Margin History
About XOMA Corp Financial Statements
XOMA Corp stakeholders use historical fundamental indicators, such as XOMA Corp's Operating Margin, to determine how well the company is positioned to perform in the future. Although XOMA Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in XOMA Corp's assets and liabilities are reflected in the revenues and expenses on XOMA Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in XOMA Corp. Please read more on our technical analysis and fundamental analysis pages.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether XOMA Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XOMA Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xoma Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xoma Corp Stock:Check out the analysis of XOMA Corp Correlation against competitors. For information on how to trade XOMA Stock refer to our How to Trade XOMA Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XOMA Corp. If investors know XOMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XOMA Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.37 | Earnings Share (3.07) | Revenue Per Share 1.862 | Quarterly Revenue Growth 7.671 | Return On Assets (0.06) |
The market value of XOMA Corp is measured differently than its book value, which is the value of XOMA that is recorded on the company's balance sheet. Investors also form their own opinion of XOMA Corp's value that differs from its market value or its book value, called intrinsic value, which is XOMA Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XOMA Corp's market value can be influenced by many factors that don't directly affect XOMA Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XOMA Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if XOMA Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XOMA Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.